
Opinion|Videos|May 16, 2025
Strategies to Minimize Toxicities, and the Pharmacist’s Role in Educating and Supporting Patients With NSCLC
Author(s)Lauren Ledbetter, PharmD, BCOP
A panelist discusses how to minimize EGFR tyrosine kinase inhibitor (TKI) adverse effects through preventive measures such as maintaining good skin regimens with moisturizers and SPF 30+ sunscreen, prescribing topical steroids and antibiotics for skin rash, and managing diarrhea with hydration, diet modifications, and loperamide.
Advertisement
Episodes in this series

Management Strategies for EGFR TKI Adverse Effects: Summary for Physicians
Dermatologic Toxicity Management
- Proactive skin care regimen before initiating EGFR TKIs:
- Recommend non–alcohol-based creamy moisturizers (morning and night)
- Daily SPF 30+ sunscreen on exposed areas
- Encourage protective clothing (hats, long sleeves)
- Treatment options for acneiform rash:
- Topical steroids
- Topical clindamycin gel
- Oral doxycycline (helps reduce severity and prevent superimposed infection)
- Consider dermatology referral for severe cases
Diarrhea Management
- Patient education:
- Instruct patients to monitor and track stool frequency above baseline
- Emphasize adequate hydration
- Dietary modifications:
- Recommend BRAT-style diet (bananas, rice, apples, toast)
- Low-fiber, bland foods
- Avoid dairy, greasy, and fatty foods
- Pharmacologic intervention:
- Provide step-by-step loperamide (Imodium) dosing instructions
- Review medication list for potential exacerbating agents
- Instruct patients to hold laxatives/stool softeners during diarrhea episodes
Clinical Pearls
- Male patients may require additional encouragement regarding skin care regimens
- Emphasize importance of patient communication between visits
- Always perform medication reconciliation to identify potential contributory medications
- Ensure patients have clear instructions for all prescribed treatments
This approach focuses on proactive management to minimize adverse events while maintaining treatment efficacy.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Yes, COVID-19 Is Still a Big Deal. Pharmacy Is the Tip of the Spear (and Needle)
2
Beat the Heat: 10 Common Medication Culprits Causing Heat Intolerance
3
FDA Fast Tracks First-in-Class TNFR2 Antibody as Chemotherapy-Free Strategy for Platinum-Resistant Ovarian Cancer
4
The Inflation Reduction Act and Oncology Drug Pricing: What Pharmacists Need to Know
5



































































































